Betaxolol: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Betaxolol. Educational only — not medical advice.

Labeled uses

BETOPTIC S® (betaxolol hydrochloride ophthalmic suspension) 0.25% is indicated for the treatment of elevated intraocular pressure (IOP) in patients with chronic open-angle glaucoma or ocular hypertension.

Source: FDA labeling via NIH DailyMed (set 905ba189…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.